{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "inhibits_modification",
    "modifications" : [ {
      "modification_type" : "phosphorylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:5957",
      "entity_text" : "ATP",
      "entity_type" : "simple_chemical"
    },
    "is_direct" : false,
    "participant_a" : {
      "in_model" : true,
      "identifier" : "hmdb:HMDB06564",
      "entity_text" : "glucose",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Cell treatment with 2-deoxyglucose (2-DG), a glucose analog that inhibits glycolysis following ATP dependent phosphorylation, reduced ATP levels within mitochondria more strongly than glucose withdrawal alone, and also markedly reduced cytosolic ATP levels (XREF_FIG).",
  "reading_complete" : "2020-08-09T07:27:17Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-09T07:25:15Z",
  "trigger" : "inhibits",
  "evidence" : [ "glucose analog that inhibits glycolysis following ATP dependent phosphorylation" ],
  "pmc_id" : "6456002",
  "score" : 0
}